Immunology

H. Groux, A. O'Garra, M. Bigler, M. Rouleau, S. Antoneko, J.E. de Vries, M.G. Roncarolo, "A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis," Nature, 389:737-42, Oct. 16, 1997. (Cited in more than 210 papers since publication) Comments by Maria Grazia Roncarolo, codirector of the Telethon Institute of Gene Therapy, Milano, Italy Maria Grazia Roncarolo has searched for more than 10 years for a way to overcome a major complication in bone marrow transplants: graf

Written byNadia Halim
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

H. Groux, A. O'Garra, M. Bigler, M. Rouleau, S. Antoneko, J.E. de Vries, M.G. Roncarolo, "A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis," Nature, 389:737-42, Oct. 16, 1997. (Cited in more than 210 papers since publication)

Comments by Maria Grazia Roncarolo, codirector of the Telethon Institute of Gene Therapy, Milano, Italy

Maria Grazia Roncarolo has searched for more than 10 years for a way to overcome a major complication in bone marrow transplants: graft-vs.-host disease (GVHD), a rejection of the recipient by the donor marrow. Even with immunosuppressive drugs, doctors often cannot control the reaction, which can be lethal. She took her clinical observations and developed some basic research tenets with the goal of helping patients.

Pictured from left: Mike Bigler, Matthieu Rouleau, Reiko Namikawa, Maria Grazia Roncarolo, Herve Groux, Meri Firpo, Nicole Carballido As a pediatrician, Roncarolo noticed some patients did not develop GVHD when mismatched ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies